Primary information |
---|
PRRID | PRRID_1095 |
Ligand Name | Lipopolysaccharide (LPS) |
Source | Gram-negative bacteria |
Sequence of ligand | CCCCCCCCCCCCCC(=O)OC(CCCCCCCCCCC)CC(=O)OC1C(C(OC(C1OP(=O)(O)O)CO)OCC2C(C(C(C(O2)OP(=O)(O)O)NC(=O)CC(CCCCCCCCCCC)O)OC(=O)CC(CCCCCCCCCCC)O)O)NC(=O)CC(CCCCCCCCCCC)OC(=O)CCCCCCCCCCC |
Length | NA |
Type | Lipopolysaccharide (LPS) |
Occurence | Natural |
Role of Ligand | LPS was also shown to play a role in alloimmune lung injury |
Name of receptor | Toll-like receptor 4 (TLR4) |
Type of receptor | Toll-like receptor (TLR) |
Source | Mice |
Localization | graft-versus-host disease (GVHD) |
Domain | NA |
Sequence of Receptor | Q9QUK6.fasta |
Swiss prot ID | Q9QUK6 |
Length Of Receptor | 835 |
Function | TLR 4 leads to an intracellular signaling pathway NF-κB and inflammatory cytokine production which is responsible for activating the innate immune system |
Assay used | NA |
PMID | 23985302 |
Year of Publication | 2013 |
Pubchem assay | Pubchem_assay |
Primary information |
---|
PRRID | PRRID_1095 |
Ligand Name | Lipopolysaccharide (LPS) |
Source | Gram-negative bacteria |
Sequence of ligand | CCCCCCCCCCCCCC(=O)OC(CCCCCCCCCCC)CC(=O)OC1C(C(OC(C1OP(=O)(O)O)CO)OCC2C(C(C(C(O2)OP(=O)(O)O)NC(=O)CC(CCCCCCCCCCC)O)OC(=O)CC(CCCCCCCCCCC)O)O)NC(=O)CC(CCCCCCCCCCC)OC(=O)CCCCCCCCCCC |
Length | NA |
Type | Lipopolysaccharide (LPS) |
Occurence | Natural |
Role of Ligand | LPS was also shown to play a role in alloimmune lung injury |
Name of receptor | Toll-like receptor 4 (TLR4) |
Type of receptor | Toll-like receptor (TLR) |
Source | Mice |
Localization | graft-versus-host disease (GVHD) |
Domain | NA |
Sequence of Receptor | Q9QUK6.fasta |
Swiss prot ID | Q9QUK6 |
Length Of Receptor | 835 |
Function | TLR 4 leads to an intracellular signaling pathway NF-κB and inflammatory cytokine production which is responsible for activating the innate immune system |
Assay used | NA |
PMID | 23985302 |
Year of Publication | 2013 |
Pubchem assay | Pubchem_assay |